Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY13.48 CNY
Change Today -0.32 / -2.32%
Volume 16.0M
600351 On Other Exchanges
As of 3:05 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

yabao pharmaceutical group-a (600351) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/15 - CNY19.50
52 Week Low
12/22/14 - CNY8.47
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for YABAO PHARMACEUTICAL GROUP-A (600351)

Related News

No related news articles were found.

yabao pharmaceutical group-a (600351) Related Businessweek News

No Related Businessweek News Found

yabao pharmaceutical group-a (600351) Details

Yabao Pharmaceutical Group Co., Ltd, a specialty pharmaceutical company, is engaged in the research and development, manufacture, and operation of western and Chinese medicines, APIs, health care products, and packing materials for medicines in China and internationally. The company’s marketed products are in cardiovascular, oncology, pediatric, and women’s health areas; and research and development programs in diabetes, inflammation, and cerebrovascular areas. It also provides finished drug products in various forms, such as tablets, injections, capsules, granules, and suppositories, as well as in powders for injections; and TCM products. In addition, the company is involved in planting and processing medicinal herbs; and producing packing material for medicine, such as plastic bottles, adhesive labels, bottles cushions, carton boxes, cartons etc. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.

Founded in 1978

yabao pharmaceutical group-a (600351) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

yabao pharmaceutical group-a (600351) Key Developments

Yabao Pharmaceuticals Announces Exclusive China Partnership with Lawson Health Research Institute

Yabao Pharmaceutical Co Inc. announced that it entered into an exclusive license with Lawson Health Research Institute to discover, develop and commercialize products based on annexin A5 for the treatment of sepsis in July 2014, and that by this month it has successfully completed discovery validation work and moved the program into preclinical development. The use of annexin A5 to treat sepsis was discovered by a team led by Dr. Qingping Feng, a scientist at Lawson and Western University. Under the terms of the agreement, Yabao receives exclusive rights to discover, develop and commercialize in China, Taiwan and Hong Kong, while Lawson retains rights in all other markets. Financial terms were not disclosed.

Yabao Pharmaceutical Group Co., Ltd Provides Earnings Guidance for the First Half of 2015

Yabao Pharmaceutical Group Co. Ltd. provided earnings guidance for the first half of 2015. According to preliminary statistics of its financial department, the company predicts a year-on-year increase of about between 45% and 55% in the net profit belonging to shareholders of listed company in the first half of 2015.

Yabao Pharmaceutical Group Co., Ltd. Announces Profit Distribution for 2014, Payable on May 29, 2015

Yabao Pharmaceutical Group Co. Ltd. announced taxes included profit distribution for 2014 of CNY 1.8 for every 10 shares, payable on May 29, 2015. Record date is May 28, 2015 and Ex-dividend date is May 29, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600351:CH CNY13.48 CNY -0.32

600351 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600351.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600351 Industry Range
Price/Earnings 48.8x
Price/Sales 4.9x
Price/Book 4.9x
Price/Cash Flow 48.4x
TEV/Sales 4.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YABAO PHARMACEUTICAL GROUP-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at